Kinoxis Therapeutics

Developer of therapies fort treating CNS disorders

placeMelbourne, Victoria, Australia calendar_todayFounded 2017 groups13 employees language kinoxistherapeutics.com

Innovation

7 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 220 times.

YearFilings
20191
20201
20213
20227
20235
20246
20254
20261

Social engagement

Social engagement: 2.8K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Uniseed, UniSuper, Stoic Venture Capital, Avicella Capital.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%

Recent activity

13 Apr 2026
Event
2nd Neuroscience Innovation Partnering & Licensing Summit
21 Aug 2025
Event
8th Annual Neuropsychiatric Drug Development Summit
Coming soon